S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Judge rules online archive's book service violated copyright
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Finnish leadership condemns attack on veteran lawmaker
Venezuela: 21 officials, businessmen arrested in oil scheme
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Judge rules online archive's book service violated copyright
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Finnish leadership condemns attack on veteran lawmaker
Venezuela: 21 officials, businessmen arrested in oil scheme
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Judge rules online archive's book service violated copyright
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Finnish leadership condemns attack on veteran lawmaker
Venezuela: 21 officials, businessmen arrested in oil scheme
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Germany, EU reach agreement in combustion engine row
Judge rules online archive's book service violated copyright
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Biden's moves on Alaska drilling, TikTok test young voters
Ruling halts oil exports from Iraq's Kurdish area via Turkey
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Finnish leadership condemns attack on veteran lawmaker
Venezuela: 21 officials, businessmen arrested in oil scheme
NASDAQ:LFVN

LifeVantage - LFVN Stock Forecast, Price & News

$3.53
+0.09 (+2.62%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.41
$3.54
50-Day Range
$3.26
$4.00
52-Week Range
$3.24
$5.05
Volume
10,272 shs
Average Volume
15,170 shs
Market Capitalization
$44.90 million
P/E Ratio
N/A
Dividend Yield
3.40%
Price Target
N/A

LifeVantage MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.32% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
0.87mentions of LifeVantage in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.33 out of 5 stars

Medical Sector

967th out of 1,005 stocks

Pharmaceutical Preparations Industry

464th out of 486 stocks


LFVN stock logo

About LifeVantage (NASDAQ:LFVN) Stock

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
LFVN.C
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Lifevantage Corporation
See More Headlines
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Company Calendar

Last Earnings
2/02/2023
Ex-Dividend for 3/15 Dividend
2/28/2023
Dividend Payable
3/15/2023
Today
3/26/2023
Next Earnings (Estimated)
5/02/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFVN
Employees
263
Year Founded
N/A

Profitability

Net Income
$3.12 million
Pretax Margin
0.26%

Debt

Sales & Book Value

Annual Sales
$206.36 million
Cash Flow
$0.83 per share
Book Value
$2.50 per share

Miscellaneous

Free Float
11,857,000
Market Cap
$44.90 million
Optionable
Optionable
Beta
1.12

Key Executives

  • Steven R. Fife
    President, Chief Executive Officer & Director
  • Matthew Cooley
    Chief Operating Officer
  • Carl Aure
    Chief Financial Officer
  • Brian Dixon
    Senior Vice President-Research & Development
  • Eric E. Marchant
    Vice President-Compliance













LFVN Stock - Frequently Asked Questions

How have LFVN shares performed in 2023?

LifeVantage's stock was trading at $3.72 at the beginning of 2023. Since then, LFVN stock has decreased by 5.1% and is now trading at $3.53.
View the best growth stocks for 2023 here
.

When is LifeVantage's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our LFVN earnings forecast
.

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) released its quarterly earnings results on Thursday, February, 2nd. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $53.66 million for the quarter. LifeVantage had a positive trailing twelve-month return on equity of 5.21% and a negative net margin of 0.35%.

How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?

LifeVantage announced a quarterly dividend on Thursday, February 2nd. Stockholders of record on Wednesday, March 1st will be paid a dividend of $0.03 per share on Wednesday, March 15th. This represents a $0.12 annualized dividend and a dividend yield of 3.40%. The ex-dividend date of this dividend is Tuesday, February 28th.
Read our dividend analysis for LFVN
.

Is LifeVantage a good dividend stock?

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.12 per share and currently has a dividend yield of 3.43%.
Read our dividend analysis for LFVN.

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage issued an update on its FY 2023 earnings guidance on Thursday, February, 2nd. The company provided earnings per share (EPS) guidance of $0.22-$0.28 for the period. The company issued revenue guidance of $202.00 million-$212.00 million, compared to the consensus revenue estimate of $206.36 million.

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

Who are LifeVantage's major shareholders?

LifeVantage's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (6.75%), Millennium Management LLC (0.54%), Morgan Stanley (0.30%), Susquehanna International Group LLP (0.20%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Darren Jay Jensen, Justin Rose and Michael A Beindorff.
View institutional ownership trends
.

How do I buy shares of LifeVantage?

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $3.53.

How much money does LifeVantage make?

LifeVantage (NASDAQ:LFVN) has a market capitalization of $44.90 million and generates $206.36 million in revenue each year. The company earns $3.12 million in net income (profit) each year or ($0.05) on an earnings per share basis.

How many employees does LifeVantage have?

The company employs 263 workers across the globe.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699.

This page (NASDAQ:LFVN) was last updated on 3/26/2023 by MarketBeat.com Staff